- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Next-week expectancy is positive at 61.41% based on similar historical setup states.
GRAL
NASDAQ
Week ended 24 Jul 2026
Weekly Investor Report
GRAIL, LLC · Healthcare · Diagnostics & Research
Latest close
67.84 USD
-6.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 0.3% above the Trend Line and sits at 42.6% of its 52-week range. The latest completed week returned -6.6%, after a 2.9% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 64/100 conviction, while the latest news-sentiment score is 22/100. Near-term considerations: volume confirmation is below normal; earnings are due in 13d.
Setup score
42
out of 100
Latest Close
67.84 USD
24 Jul 2026
1W Return
-6.6%
latest completed week
4W Return
2.9%
short-term follow-through
12W Return
25.5%
quarterly tape
Trend Breadth
46.2%
24 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-6.6%
Latest completed week; four-week move 2.9%.
Indicator stack
25/59
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 61.41%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Volatility
64/100 conviction; expected move 19.3%.
News sentiment
22/100
14 relevant articles in the latest sentiment read.
Event risk
13d
Next report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 0.3% above the Trend Line and sits at 42.6% of its 52-week range. The latest completed week returned -6.6%, after a 2.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
30 Jan
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3512-week average 0.18
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.35Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.9% over four weeks, 25.5% over 12 weeks, and 68.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year24
Trend breadth46.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.51Latest activity-pressure read.
Pressure change2.1%Four-week change in activity pressure.
Leadership-7.08Latest relative-leadership reading.
RS change34.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Dec 2025
Field coverage 82%
Model confidence 78%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength20/100Blend of value, momentum, and quality. Underlying universe rank 81; rank 1 is best.
Value25/100Relative valuation strength. Underlying universe rank 76; rank 1 is best.
Quality5/100Profitability and accounting quality. Underlying universe rank 96; rank 1 is best.
Momentum90/100Medium-term price momentum. Underlying universe rank 11; rank 1 is best.
Growth78/100Revenue and earnings growth. Underlying universe rank 23; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- 18.6x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -10.0% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- -14.8% Gross profit retained from each unit of revenue.
- Operating margin
- -316.2% Operating profit retained from revenue.
- Free-cash-flow margin
- -185.1% Free cash flow generated from revenue.
- Return on invested capital
- -14.9% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 19.4% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -14.4% Net share repurchases relative to market value.
- Shareholder yield
- -14.4% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.1x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningVolatility
GRAL shows volatility options pressure with a 64/100 conviction score, put-call volume ratio of 6.56, expected move of 19.3%, and Sharemaestro trend signal inactive.
Conviction64/100
Expected move19.3%
Put/call volume6.56
Insider activity-
No recent insider transactions are stored for this company.
News sentiment22/100
Weighted news tone is negative across 14 relevant articles.
0 positive · 1 neutral · 13 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings13dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
Options expected move19.3%Nearest-chain priced movement where available.
52-week drawdown-42.9%Distance below the 52-week high.
13-week volatility7.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
30 Jan
27 Feb
27 Mar
24 Apr
22 May
19 Jun
24 Jul
Weeks higher15 of 2611 weeks finished lower.
Best week+14.0%Week of 8 May.
Worst week-48.5%Week of 20 Feb.
Latest week-6.6%Week of 24 Jul.
Shape of recent returns
Strong gains11
Modest gains4
Flat weeks0
Modest losses4
Sharp losses7
Recent vol7.7%13-week weekly-return volatility.
Base vol12.3%52-week weekly-return volatility.
Up/down split33/19Count of positive and negative weeks in the 52-week window.
Average skew8.5% / -9.7%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average1.3%
Trend breadth51.0%
Trend51.0%active weekly trend signals
MD75.0%positive activity pressure
RS48.0%positive relative leadership
Four-week leaders
IndustryUS Diagnostics & Research
4-week rank15 / 45
Group average6.3%
Trend breadth48.9%
Trend48.9%active weekly trend signals
MD82.2%positive activity pressure
RS42.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape37/100
Trend, activity pressure, participation, and risk combine to a 37/100 tape read.
Indicator analysis29/100Latest 12-week confirmation: trend 0/12, activity pressure 8/12, relative leadership 0/12.
Activity pressure 0.35; No reversal markers Next-Week ExpectancyPositive 61.41%Next-week expectancy is positive with a 61.41% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors31/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 89; Small Cap Core rank 78 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options59/100GRAL shows volatility options pressure with a 64/100 conviction score, put-call volume ratio of 6.56, expected move of 19.3%, and Sharemaestro trend signal inactive.
Volatility · Volatility expansion watch · Expected move 19.3% Sentiment22/100Weighted news tone is negative across 14 relevant articles.
GRAL Court Deadline: GRAIL, Inc. Investor Deadline in Securities Fraud Class Action is August 4 – Contact BFA Law if You Lost Money Insiders50/100No recent insider transaction evidence is stored.
Earnings13dNext report is scheduled for 11 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 24 Jul 2026 | 67.84 USD | -6.6% | 67.67 USD | 45.43 USD | 0.51 | -7.08 | 2.3M | Off |
| 17 Jul 2026 | 72.62 USD | 0.9% | 68.46 USD | 45.22 USD | 0.56 | -1.63 | 2.1M | Off |
| 10 Jul 2026 | 72.00 USD | 4.2% | 69.08 USD | 44.97 USD | 0.50 | -5.82 | 2.9M | Off |
| 3 Jul 2026 | 69.11 USD | 4.8% | 69.70 USD | 44.71 USD | 0.43 | -7.53 | 1.7M | Off |
| 26 Jun 2026 | 65.92 USD | 3.4% | 70.77 USD | 44.48 USD | 0.50 | -10.83 | 3.9M | Off |
| 19 Jun 2026 | 63.74 USD | 6.5% | 72.25 USD | 44.27 USD | 0.50 | -17.59 | 2.9M | Off |
| 12 Jun 2026 | 59.85 USD | -0.2% | 73.24 USD | 44.08 USD | 0.41 | -20.56 | 3.0M | Off |
| 5 Jun 2026 | 59.98 USD | -16.3% | 73.90 USD | 43.93 USD | 0.25 | -18.49 | 7.0M | Off |
| 29 May 2026 | 71.68 USD | 6.7% | 74.55 USD | 43.77 USD | -0.03 | -6.76 | 3.9M | Off |
| 22 May 2026 | 67.19 USD | 12.6% | 75.22 USD | 43.49 USD | -0.42 | -9.69 | 2.6M | Off |
| 15 May 2026 | 59.65 USD | -3.2% | 75.96 USD | 43.25 USD | -0.67 | -18.63 | 2.8M | Off |
| 8 May 2026 | 61.64 USD | 14.0% | 76.57 USD | 43.09 USD | -0.86 | -16.07 | 3.6M | Off |
| 1 May 2026 | 54.06 USD | -0.7% | 76.72 USD | 42.89 USD | -1.00 | -22.14 | 2.6M | Off |
| 24 Apr 2026 | 54.42 USD | 5.2% | 77.11 USD | 42.78 USD | -1.04 | -20.31 | 2.4M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.